Provided by Tiger Trade Technology Pte. Ltd.

Adverum Biotechnologies

4.36
0.0000
Volume:- -
Turnover:4.42M
Market Cap:96.26M
PE:-0.51
High:4.36
Open:4.36
Low:4.36
Close:4.36
52wk High:6.07
52wk Low:1.78
Shares:22.08M
Float Shares:11.36M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5585
EPS(LYR):-6.6185
ROE:-417.79%
ROA:-76.90%
PB:-1.73
PE(LYR):-0.66

Loading ...

Adverum reports completion of screening for Phase 3 ARTEMIS trial

TIPRANKS
·
Sep 22, 2025

Adverum Biotechnologies Inc - Artemis Trial Data Readout Accelerated to Q1 2027

THOMSON REUTERS
·
Sep 22, 2025

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration

GlobeNewswire
·
Sep 22, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 06, 2025

Adverum Biotechnologies Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12, 2025

Adverum Biotechnologies Q2 EPS $(2.34) Misses $(2.21) Estimate

Benzinga
·
Aug 12, 2025

Adverum Biotechnologies Posts Q2 2025 Net Loss of $49.2M, EPS at $2.34, R&D Expenses Surge Due to ARTEMIS Trial

Reuters
·
Aug 12, 2025

Adverum Biotechnologies Inc - Artemis Enrollment Completion Expected in 1Q 2026, Topline Data Anticipated 1H 2027

THOMSON REUTERS
·
Aug 12, 2025

Adverum Biotechnologies: Luna 2-Year Long-Term Follow-up Data Planned in 4Q 2025

THOMSON REUTERS
·
Aug 12, 2025

Adverum Biotechnologies, Inc. Q2 Operating Expenses USD 49.855 Million

THOMSON REUTERS
·
Aug 12, 2025

Adverum Biotechnologies, Inc. Q2 Net Income USD -49.191 Million

THOMSON REUTERS
·
Aug 12, 2025

Adverum Biotechnologies, Inc. Q2 Basic EPS USD -2.34

THOMSON REUTERS
·
Aug 12, 2025

Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights

GlobeNewswire
·
Aug 12, 2025

Adverum Biotechnologies Inc expected to post a loss of $2.25 a share - Earnings Preview

Reuters
·
Aug 08, 2025

Mizuho Cuts Price Target on Adverum Biotechnologies to $12 From $16, Keeps Outperform Rating

MT Newswires Live
·
Jun 26, 2025

Adverum Biotechnologies Inc. Conducted Annual Stockholder Meeting

Reuters
·
Jun 18, 2025

U.S. RESEARCH ROUNDUP-Alphabet, Booking Holdings, Meta

Reuters
·
Jun 17, 2025